Title: The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors.
Journal: Anesthesia and analgesia 20151201
Title: A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures.
Journal: Therapeutic advances in neurological disorders 20150701
Title: Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy.
Journal: Expert opinion on drug metabolism & toxicology 20150401
Title: Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.
Journal: Pharmacology research & perspectives 20150301
Title: Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.
Journal: Epilepsia 20150201
Title: Clinical utility of eslicarbazepine: current evidence.
Journal: Drug design, development and therapy 20150101
Title: Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.
Journal: BMC neurology 20150101
Title: Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study.
Journal: Epilepsy research 20140901
Title: The effects of eslicarbazepine on persistent Na⁺ current and the role of the Na⁺ channel β subunits.
Journal: Epilepsy research 20140201
Title: Aptiom (eslicarbazepine acetate) as a dual inhibitor of β-secretase and voltage-gated sodium channel: advancement in Alzheimer's disease-epilepsy linkage via an enzoinformatics study.
Journal: CNS & neurological disorders drug targets 20140101
Title: Pharmacokinetics and drug interactions of eslicarbazepine acetate.
Journal: Epilepsia 20120601
Title: [Eslicarbazepine acetate: a novel therapeutic alternative in the treatment of focal seizures].
Journal: Revista de neurologia 20120501
Title: Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
Journal: Expert opinion on pharmacotherapy 20120401
Title: Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis 20120305
Title: Pharmacokinetics, drug interactions and exposure-response relationship of eslicarbazepine acetate in adult patients with partial-onset seizures: population pharmacokinetic and pharmacokinetic/pharmacodynamic analyses.
Journal: CNS drugs 20120101
Title: Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.
Journal: The Cochrane database of systematic reviews 20111207
Title: Eslicarbazepine acetate for partial-onset seizures.
Journal: Expert review of neurotherapeutics 20111201
Title: In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.
Journal: Epilepsia 20111001
Title: [New antiepileptic drugs, and therapeutic considerations].
Journal: Ideggyogyaszati szemle 20110930
Title: Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110901
Title: Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
Journal: Epilepsy research 20110901
Title: Development and validation of an enantioselective liquid-chromatography/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110901
Title: [Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
Journal: Der Nervenarzt 20110601
Title: A chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5-carboxamide derivatives in mouse plasma and brain tissue: eslicarbazepine acetate, carbamazepine and main metabolites.
Journal: Journal of separation science 20110601
Title: Development of liquid chromatographic enantiomer separation methods and validation for the estimation of (R)-enantiomer in eslicarbazepine acetate.
Journal: Journal of pharmaceutical and biomedical analysis 20110105
Title: Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
Journal: Epilepsia 20101001
Title: Enantioselective assay for therapeutic drug monitoring of eslicarbazepine acetate: no interference with carbamazepine and its metabolites.
Journal: Therapeutic drug monitoring 20100801
Title: Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers.
Journal: Epilepsy & behavior : E&B 20100801
Title: Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
Journal: Current medical research and opinion 20100601
Title: Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma.
Journal: Analytical and bioanalytical chemistry 20100601
Title: Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Journal: Epilepsy research 20100501
Title: Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects.
Journal: Acta neurologica Scandinavica 20100401
Title: Key factors in the discovery and development of new antiepileptic drugs.
Journal: Nature reviews. Drug discovery 20100101
Title: Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Journal: Clinical therapeutics 20100101
Title: Eslicarbazepine acetate: A novel agent for the adjunctive treatment of epilepsy.
Journal: Drugs of today (Barcelona, Spain : 1998) 20100101
Title: Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
Journal: Acta neurologica Scandinavica 20091101
Title: Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
Journal: Fundamental & clinical pharmacology 20090801
Title: Effect of eslicarbazepine acetate on the pharmacokinetics of metformin in healthy subjects.
Journal: International journal of clinical pharmacology and therapeutics 20090401
Title: Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Journal: Epilepsia 20090301
Title: Eslicarbazepine acetate: a new option for the treatment of focal epilepsy.
Journal: Expert opinion on investigational drugs 20090201
Title: Eslicarbazepine acetate.
Journal: CNS drugs 20090101
Title: Disposition of eslicarbazepine acetate in the mouse after oral administration.
Journal: Fundamental & clinical pharmacology 20081001
Title: Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy.
Journal: Journal of clinical pharmacology 20080801
Title: Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment.
Journal: European journal of clinical pharmacology 20080301
Title: Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.
Journal: International journal of clinical pharmacology and therapeutics 20080301
Title: Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers.
Journal: Drugs in R&D 20080101
Title: Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma.
Journal: Biomedical chromatography : BMC 20071101
Title: Effect of eslicarbazepine acetate (BIA 2-093) on latrunculin A-induced seizures and extracellular amino acid concentrations in the rat hippocampus.
Journal: Epilepsy research 20071001
Title: Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection.
Journal: Analytica chimica acta 20070716
Title: Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker.
Journal: Biopharmaceutics & drug disposition 20070701
Title: Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
Journal: Epilepsia 20070301
Title: Eslicarbazepine acetate (BIA 2-093).
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20070101
Title: Anticonvulsant effect of eslicarbazepine acetate (BIA 2-093) on seizures induced by microperfusion of picrotoxin in the hippocampus of freely moving rats.
Journal: Epilepsy research 20061201
Title: Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects.
Journal: Journal of clinical pharmacology 20050901
Title: Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093).
Journal: Drugs in R&D 20050101
Title: Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations.
Journal: Drugs in R&D 20050101
Title: Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093.
Journal: Epilepsia 20041201
Title: Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans.
Journal: Journal of clinical pharmacology 20040801
Title: Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans.
Journal: Drugs in R&D 20030101
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
Title: The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine.
Journal: Neurochemistry international 20020401
Title: Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices.
Journal: Pharmacology & toxicology 20020401
Title: Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.
Journal: Neurochemical research 20020201
Title: Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels.
Journal: Biochemical pharmacology 20010515
Title: Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine.
Journal: Epilepsy research 20010501
Title: Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine.
Journal: Epilepsia 20010501
Title: Sibhghatulla Shaikh, et al. Aptiom (Eslicarbazepine Acetate) as a Dual Inhibitor of β-Secretase and Voltage-Gated Sodium Channel: Advancement in Alzheimer's Disease-Epilepsy Linkage via an Enzoinformatics Study. CNS & Neurological Disorders Drug Targets Volume 13 , Issue 7 , 2014.
